I try to remind myself that there are glorious days of fall to enjoy yet. Crisp nights will bring out the autumn colors, and we’ll have warm days to view a patchwork of colored leaves. The grapes just ...

These groundbreaking results offer hope for the FUS-ALS community and represent an exciting milestone in our efforts to transform the treatment of this rare, rapidly progressive and fatal form of ...

Coya has received IND (Investigational New Drug) approval to test Coya 302 in FTD. This trial will apply the same Treg-restoration science to a different neurodegenerative disease. Recruitment will ...

Molecular changes involving inflammation and protein processing were detected before ALS-like symptoms appeared in a SOD1 mouse model. Activity of genes including SOD1 and Il33 differed in the mouse ...

But what about all our plans?” I asked my husband right after receiving my ALS diagnosis in 2024. “We’ve got places to go, ...

Researchers identified 10 altered genes that may serve as effective diagnostic and tracking biomarkers for ALS. The study highlighted existing drugs and supplements that could potentially target these ...

Acelot has dosed the first healthy volunteer in a Phase 1a clinical trial testing ACE-2223, its investigational oral treatment candidate designed to target aggregated TDP-43 in people with amyotrophic ...

Geneuro received a European patent for GNK-301, an antibody targeting K Env, with Phase 1 trials planned for the second half of 2027.